Tosin Afolabi, MD

internal medicine resident @weillcornell, @templemedschool @nyuniversity alum, she/her. tweets are my own

[Tosin Afolabi, MD @almostdrtosin]

@RandolphLydePhD @PittGIM @PittHemeOnc Congratulations, Randy!!

[Westin Wong @WestinWong]

stop: stressing about match
start: stressing about finding a place to live

[Tosin Afolabi, MD @almostdrtosin]

@almostdrtosin lol

[Tosin Afolabi, MD @almostdrtosin]

Comparison is truly the thief of joy. Run your own race, focus on your own path, you’ve worked so hard to get to where you are right now! Everything is going to work out exactly how it’s supposed to. #ERAS2024

[Tosin Afolabi, MD @almostdrtosin]

This is absolutely disgusting.

[Saturday Night Live @nbcsnl]

that’s just yankee swap

[Pat McGann, MD @PTMcGann]

Absolutely absurd @nbcsnl @kenanthompson

#SickleCell is not a joke and this type of racist nonsense perpetuates the the problem. I am beyond words

[Tosin Afolabi, MD @almostdrtosin]

We absolutely LOVE to see it! #SickleCellDisease

[Boston Children's @BostonChildrens]

Today, the FDA approved the first CRISPR therapy to treat #sicklecell disease, developed at Boston Children's! Read how Drs. Stu Orkin, @bloodgenes, & @danielevanbauer found they could activate life-sustaining hemoglobin proteins in sickle cell patients. https://t.co/XZqFEqAGJR

[Chidinma Chi-Chi Osuagwu, MD @AhunnayaChi]

Now to address affordability and access.

(And I guess we can therefore sidestep questioning the length of time required to acquire adequate funding for researching treatment of a condition as pervasive and debilitating as SCD)

[Marilyn Heine @MarilynHeineMD]

@DrTazKhalid Deeply concerning!

In 2022 AMA survey of >1000 physicians:

33% said prior auth has led to a serious adverse event for a patient in their care

9% said prior auth has led to a patient’s disability/permanent bodily damage, congenital anomaly/birth defect or death

#FixPriorAuth

[Tosin Afolabi, MD @almostdrtosin]

Comparison is truly the thief of joy. Run your own race, focus on your own path, you’ve worked so hard to get to where you are right now! Everything is going to work out exactly how it’s supposed to. #ERAS2024

[Adeiyewunmi (Ade) Osinubi, MD @Ade_Osinubi]

I wrote this piece for @Essence about the realities of living with #sicklecelldisease (SCD), surviving a bone marrow transplant and the impact of SCD on self esteem, relationships, and everything in between. #Medtwitter

Read here: https://t.co/sQxCF0pfTg

[Tosin Afolabi, MD @almostdrtosin]

OB/GYN is sooo lucky to be getting you, Simi 🎉

[Simisola Tani-Olugbemi @SimisolaTani]

Aaand apps are in!

Hey #MedTwitter/#MedX!

My name is Simi Tani-Olugbemi and I am beyond excited to be applying to #ObGynMatch2024!

I am passionate about sexual health, advocacy, and patient education. Looking forward to connecting along the interview trail!

[Onyinye Balogun MD, MSc @GlobalRadOnc]

Ableism should not prevent someone from experiencing the phenomenon that is Renaissance! Pls @Beyonce @RenaissanceWT help this individual see the show. #RENAISSANCEWorldTour

[Tosin Afolabi, MD @almostdrtosin]

🚨🚨🚨

[Chidinma Chi-Chi Osuagwu, MD @AhunnayaChi]

Thanks to my co-authors - @tisaneg , Drs. Morse, Wispelwey, Mills

https://t.co/qvMeuFphr9

This paper was a reminder that there is so much study I need to revisit, relearn, & continued work to undo.

[Chidinma Chi-Chi Osuagwu, MD @AhunnayaChi]

Thanks to my co-authors - @tisaneg , Drs. Morse, Wispelwey, Mills

https://t.co/qvMeuFphr9

This paper was a reminder that there is so much study I need to revisit, relearn, & continued work to undo.

[Tosin Afolabi, MD @almostdrtosin]

@ChiOsuagwu_ 🥰🥰🥰

[Tosin Afolabi, MD @almostdrtosin]

My favorite bittersweet moment is patients asking me to be their PCP when they leave the hospital but having to tell them that I’m still a student 🥰🥲

[Victor Jegede @VictorOJegede]

Hey #MedTwitter! My name is Victor and I’m a 4th year student @templemedschool applying into Otolaryngology for the 2024 match!

Looking forward to connecting with #ENT mentors and colleagues over the next few months!

[Michael Justus @mhjrad]

"So the activated C1 cleaves C4 into C4a and C4b, which binds to the microbial surface. C4b then binds C2, which is cleaved by C1s into C2a and C2b, forming the C4b2b complex, also known as C3 convertase, which cleaves C3 into C3a and C3b."

[Tosin Afolabi, MD @almostdrtosin]

@DelafieldNathan @PaulNWilliamz @templemedschool @MayoAZ_IMRES @MayoEquity @MayoClinic I definitely will! Thanks, Dr. Delafield!

[Tosin Afolabi, MD @almostdrtosin]

Hi #MedTwitter (#MedX?)! My name is Tosin Afolabi and I am an M4 at @templemedschool applying Internal Medicine. I love all things health equity, community advocacy and evidence based medicine. I’m so excited to connect with future colleagues and make new friends!

[Tosin Afolabi, MD @almostdrtosin]

@Alexander_Worix @templemedschool @NU_IntMed Oh absolutely! I look forward to learning more about the program!